Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG > Summary
Court Case Number IPR2020-01317
Filing Date Jul 16, 2020
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesRobert L. Kinder, Erica A. Franklin, Kristi L. R. Sawert
Judge Writing the Final DecisionRobert L. Kinder
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
Petitioner
Patent Owner
Petitioner Attorneys
7Regeneron Pharmaceuticals
Attorney Name: Christopher M. Pepe
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Natalie Carol Kennedy
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Andrew P. Gesior
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Timothy J. Andersen
Weil, Gotshal & Manges
Attorney Name: Brian E. Ferguson
Weil, Gotshal & Manges
Attorney Name: Anish R. Desai
Weil, Gotshal & Manges
Patent Owner Attorneys
6NOVARTIS PHARMA AG
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP
NOVARTIS PHARMA AG
Attorney Name: William G. James II
Goodwin Procter LLP
NOVARTIS PHARMA AG
Attorney Name: Linnea P. Cipriano
Goodwin Procter LLP
NOVARTIS PHARMA AG
Attorney Name: Michael P. Mazza
Novartis
NOVARTIS PHARMA AG
Attorney Name: Daniel J. Woods
Novartis
Attorney Name: Joshua S. Weinger
Goodwin Procter LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09220631 | Syringe | Dec 29, 2015 |
